FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Debate Intensifies Over Politicization of mRNA Vaccines

FDAs refusal to review Modernas mRNA influenza vaccine reignites concerns that vaccine policy particularly involving mRNA technology is becoming inc...

latest-news-card-1
Animal Drugs

FDA Warns Elanco Animal Health About Pradalex Ads

The Center for Veterinary Medicine warns Elanco Animal Health about false and misleading claims in promotional materials for its Pradalex that treats ...

latest-news-card-1
Human Drugs

CGMP Issues at Australias Cosmetic Manufacturers Pty

FDA warns Australias Cosmetics Manufacturers about CGMP violations in its production of drugs as a contract manufacturer.

latest-news-card-1
Human Drugs

Compass Pathways Reports 2nd Positive Trial for Depression Drug

Compass Pathways reports that its investigational psilocybin therapy met the primary endpoint in a second pivotal Phase 3 trial for treatment-resistan...

Medical Devices

Trividia True Metrix Glucose Monitor Early Alert

An FDA Early Alert says Trividia Health has issued updated use instructions for its True Metrix blood glucose monitors to emphasize the need to seek i...

latest-news-card-1

Senate HELP Committee: 15 Ways to Reform FDA

The Senate HELP Committee offers an initial 15 recommendations for reforming FDA as part of what it says will be a collaborative, bipartisan process.

latest-news-card-1
Human Drugs

FDA DTC Crackdown Reshapes Industry Creative Approach

Drug advertising consultant Bob Ehrlich says the recent wave of FDA enforcement letters on drug promotion activities is reshaping how pharmaceutical c...

latest-news-card-1
Medical Devices

FDA Shifts to Risk-Based Device Inspections under QMSR

As part of FDAs recent implementation of the Quality Management System Regulation, a new risk-based inspection model is set to change medical device o...

latest-news-card-1
Human Drugs

PTC Yanks Translarna NDA After FDA Signals Data Shortfall

PTC Therapeutics withdraws its NDA resubmission for Translarna (ataluren) to treat nonsense mutation Duchenne muscular dystrophy, following feedback f...

latest-news-card-1
Human Drugs

Cotton Urges FDA Probe Into Chinese APIs for GLP-1 Drugs

Sen. Tom Cotton (R-AR) urges FDA to investigate whether illegal or unregulated Chinese-sourced active pharmaceutical ingredients have entered the U.S....